On ECHEMI
Home > Drugs > Diaoyutai Pharmaceutical Group Jilin Changqing Pharmaceutical Co., Ltd.
Diaoyutai Pharmaceutical Group Jilin Changqing Pharmaceutical Co., Ltd.
  • Founded in:

    1997-01-23
  • Country:

    China China
  • Address:

    No. 50, Changqing Road, Liuhe County, Tonghua City, Jilin Province
  • Tax NO.:

    91220501125581822P
  • Registered Funds:

    60.09 million yuan
  • Website:

  • Email:

Related Drugs
Compound Bifendate Granules
This product is a compound preparation, and each bag contains bifendate, inosine and vitamin C.
Name Description Content CAS NO. Registered Holders
Bifendate

Reduce liver damage and elevated alanine aminotransferase (ALT) caused by carbon tetrachloride; inhibit liver microsomal lipid peroxidation and the metabolic conversion of carbon tetrachloride into carbon monoxide; reduce the consumption of reduced coenzyme II and oxygen during carbon tetrachloride metabolism, and protect the structure and function of liver cell biomembrane; promote liver regeneration in mice with partial hepatectomy; have a significant inducing effect on cytochrome P450 enzyme activity, and enhance the detoxification ability of carbon tetrachloride and certain carcinogens; improve protein metabolism in some hepatitis patients, increase albumin and decrease globulin.

More

Reduce liver damage and elevated alanine aminotransferase (ALT) caused by carbon tetrachloride; inhibit liver microsomal lipid peroxidation and the metabolic conversion of carbon tetrachloride into carbon monoxide; reduce the consumption of reduced coenzyme II and oxygen during carbon tetrachloride metabolism, and protect the structure and function of liver cell biomembrane; promote liver regeneration in mice with partial hepatectomy; have a significant inducing effect on cytochrome P450 enzyme activity, and enhance the detoxification ability of carbon tetrachloride and certain carcinogens; improve protein metabolism in some hepatitis patients, increase albumin and decrease globulin.

73536-69-3 12
Inosine

It directly penetrates the cell membrane into the cell, converts into inosinic acid and adenosine triphosphate, and participates in liver cell energy metabolism and protein synthesis; it increases the activity of various enzymes (especially coenzyme A and pyruvate oxidase), activates liver function, and promotes the recovery of damaged liver.

More

It directly penetrates the cell membrane into the cell, converts into inosinic acid and adenosine triphosphate, and participates in liver cell energy metabolism and protein synthesis; it increases the activity of various enzymes (especially coenzyme A and pyruvate oxidase), activates liver function, and promotes the recovery of damaged liver.

58-63-9 8
Ascorbic Acid

Participates in the formation of antibodies and collagen, tissue repair (including certain redox reactions), metabolism of phenylalanine, tyrosine, and folic acid; promotes the utilization of iron and carbohydrates and the synthesis of fat and protein; maintains immune function.

More

Participates in the formation of antibodies and collagen, tissue repair (including certain redox reactions), metabolism of phenylalanine, tyrosine, and folic acid; promotes the utilization of iron and carbohydrates and the synthesis of fat and protein; maintains immune function.

50-81-7 28
Ferrous Fumarate Capsules
Each capsule of this product contains the main ingredient ferrous fumarate 0.2g (equivalent to 66mg of iron).
Name Description Content CAS NO. Registered Holders
Ferrous fumarate

Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.

More

Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.

0.2g 141-01-5 14
Compound Methionine Choline Tablets
It is composed of nine drugs including methionine, bitartrate and vitamin B12.
Name Description Content CAS NO. Registered Holders
L-Methionine

One of the essential amino acids for the human body, it provides a methyl group in the process of synthesizing choline in the body; it has a fat-removing effect similar to choline and has a significant inhibitory effect on fat accumulation in the liver.

More

One of the essential amino acids for the human body, it provides a methyl group in the process of synthesizing choline in the body; it has a fat-removing effect similar to choline and has a significant inhibitory effect on fat accumulation in the liver.

63-68-3 12
Tartaric acid

A precursor substance that supplies methyl groups and is an important component for the synthesis of choline; it has a certain inhibitory effect on the proliferation of liver collagen in the cirrhosis model.

More

A precursor substance that supplies methyl groups and is an important component for the synthesis of choline; it has a certain inhibitory effect on the proliferation of liver collagen in the cirrhosis model.

0
Folic acid

A precursor substance that provides methyl groups and is an important component in the synthesis of choline.

More

A precursor substance that provides methyl groups and is an important component in the synthesis of choline.

59-30-3 17
Vitamin B series

A precursor substance that supplies methyl groups, it has a fat-driving effect and is involved in promoting the synthesis of phospholipids and lipoproteins to utilize or store intrahepatic fat.

More

A precursor substance that supplies methyl groups, it has a fat-driving effect and is involved in promoting the synthesis of phospholipids and lipoproteins to utilize or store intrahepatic fat.

0
Vitamin B12

Participates in the synthesis of choline, indirectly promoting fat metabolism and improving liver function.

More

Participates in the synthesis of choline, indirectly promoting fat metabolism and improving liver function.

68-19-9 16
Aminocaproic acid tablets
Chemical name: 6-aminohexanoic acid
Name Description Content CAS NO. Registered Holders
6-Aminocaproic acid

This product is an antifibrinolytic drug. It binds to the lysine binding sites on plasminogen and plasmin, inhibiting the binding of plasminogen to fibrin and preventing its activation, thereby inhibiting fibrinolysis; at high concentrations, it directly inhibits the activity of plasmin and achieves a hemostatic effect.

More

This product is an antifibrinolytic drug. It binds to the lysine binding sites on plasminogen and plasmin, inhibiting the binding of plasminogen to fibrin and preventing its activation, thereby inhibiting fibrinolysis; at high concentrations, it directly inhibits the activity of plasmin and achieves a hemostatic effect.

60-32-2 6
Cephalexin and Trimethoprim Capsules
Each tablet contains 125mg of cephalexin and 25mg of trimethoprim
Name Description Content CAS NO. Registered Holders
Cephalexin

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls and inhibits or kills bacteria; when used in combination with trimethoprim, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.

More

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls and inhibits or kills bacteria; when used in combination with trimethoprim, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.

125mg 15686-71-2 33
Trimethoprim

Used in combination with cephalexin, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.

More

Used in combination with cephalexin, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.

25mg 738-70-5 44
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.